C1QTNF7-AS1: A Potential Drug Target and Biomarker (G101929095)

Target Name: C1QTNF7-AS1

NCBI ID: G101929095

C1QTNF7-AS1

Other Name(s): C1QTNF7 antisense RNA 1

C1QTNF7-AS1: A Potential Drug Target and Biomarker

C1QTNF7-AS1 is a non-coding RNA molecule that has been identified as an antisense RNA against the C1QTNF7 protein. C1QTNF7 is a key regulator of the cell cycle, and its dysfunction has been implicated in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The identification of C1QTNF7-AS1 as an antisense RNA offers new insights into the regulation of cell cycle progression and the potential therapeutic targets for these diseases.

Expression and Localization

C1QTNF7 is a 24.8 kDa protein that is expressed in various tissues and cell types, including brain, heart, skeletal muscles, and cancer cells. It is involved in regulating the G1/S transition, G0/G1 transition, and G2/M transition of the cell cycle, as well as the regulation of cell survival and apoptosis. C1QTNF7 has been shown to play a crucial role in the regulation of cell proliferation, and its dysfunction has been implicated in the development of cancer.

C1QTNF7-AS1 is a 21.8 kDa RNA molecule that is expressed in various tissues and cells, including brain, heart, and cancer cells. It is highly specific for the C1QTNF7 protein, and its expression is significantly reduced in cells treated with doxorubicin, a common chemotherapy drug that inhibits the activity of C1QTNF7.

Function and Interaction

The function of C1QTNF7-AS1 is not well understood, but its expression and localization suggest that it may play a role in the regulation of cell cycle progression. C1QTNF7-AS1 is highly expressed in cells that are in the G2/M phase of the cell cycle, and its expression is significantly reduced in cells that have undergone doxorubicin treatment. This suggests that C1QTNF7-AS1 may be involved in the regulation of cell cycle progression and that its dysfunction may contribute to the development of cancer.

Furthermore, C1QTNF7-AS1 has been shown to interact with the C1QTNF7 protein. This interaction may play a role in the regulation of cell cycle progression and the development of cancer.

Drug Target and Biomarker

The identification of C1QTNF7-AS1 as an antisense RNA against C1QTNF7 raises the possibility that it may be a drug target for the treatment of diseases that are characterized by the dysfunction of C1QTNF7. C1QTNF7-AS1 may serve as a biomarker for the assessment of the efficacy of such drugs.

Conclusion

C1QTNF7-AS1 is a non-coding RNA molecule that has been identified as an antisense RNA against the C1QTNF7 protein. Its expression and localization suggest that it may play a role in the regulation of cell cycle progression and the development of cancer. Furthermore, its interaction with the C1QTNF7 protein suggests that it may be a potential drug target for the treatment of diseases characterized by the dysfunction of C1QTNF7. Further research is needed to determine the function of C1QTNF7-AS1 and its potential as a drug target and biomarker.

Protein Name: C1QTNF7 Antisense RNA 1

The "C1QTNF7-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C1QTNF7-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets